Jonathan Adams
Chief Executive Officer at Cortigent, Inc.
Profile
Jonathan Adams is the founder of LAT Pharma LLC, which was founded in 2007.
He held the title of Chief Executive Officer at LAT Pharma LLC.
Mr. Adams is currently the President, Chief Executive Officer & Director at Cortigent, Inc. since 2023.
Mr. Adams previously worked at BioVie, Inc. as the Executive Vice President-Liver Disease Program from 2016 to 2023.
He also worked at Celebrex North America as a Member.
Mr. Adams received his undergraduate degree from Cornell University in 1985 and his MBA from Tuck School of Business at Dartmouth in 1989.
Jonathan Adams active positions
| Companies | Position | Start |
|---|---|---|
Cortigent, Inc.
 Cortigent, Inc. Medical SpecialtiesHealth Technology Cortigent, Inc. engages in developing targeted neurostimulation systems to help patients recover critical body functions. The company was founded in November 2022 and is headquartered in Valencia, CA. | Chief Executive Officer | 2023-02-28 |
Former positions of Jonathan Adams
| Companies | Position | End |
|---|---|---|
| BIOVIE INC. | Chief Executive Officer | 2018-07-02 |
| Celebrex North America | Corporate Officer/Principal | - |
LAT Pharma LLC
 LAT Pharma LLC BiotechnologyHealth Technology LAT Pharma LLC operates as an early stage biotechnology company which engages in the discovery, development and commercialization of antibiotics. The company was founded in 2006 and is headquartered in Chicago, IL. | Chief Executive Officer | - |
Training of Jonathan Adams
| Cornell University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOVIE INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Celebrex North America | |
LAT Pharma LLC
LAT Pharma LLC BiotechnologyHealth Technology LAT Pharma LLC operates as an early stage biotechnology company which engages in the discovery, development and commercialization of antibiotics. The company was founded in 2006 and is headquartered in Chicago, IL. | Health Technology |
Cortigent, Inc.
Cortigent, Inc. Medical SpecialtiesHealth Technology Cortigent, Inc. engages in developing targeted neurostimulation systems to help patients recover critical body functions. The company was founded in November 2022 and is headquartered in Valencia, CA. | Health Technology |
- Stock Market
- Insiders
- Jonathan Adams
